GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Accounts Payable

Curocell (XKRX:372320) Accounts Payable : ₩0.00 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Accounts Payable?

Curocell's Accounts Payable for the quarter that ended in Jun. 2023 was ₩0.00 Mil.


Curocell Accounts Payable Historical Data

The historical data trend for Curocell's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Accounts Payable Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
- - - - -

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Accounts Payable - - - -

Curocell Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Curocell Accounts Payable Related Terms

Thank you for viewing the detailed overview of Curocell's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines